CCME.BO · BSE
CCME GLOBAL LIMITED
₹43.9
+5.00% (+₹2.09)
Prev. close
₹41.81
Volume
6,377
As of
BSE · may be slightly delayed · 09:37 IST
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About CCME GLOBAL LIMITED
CCME Global Limited does not have significant operations. The company was previously engaged in the manufacturing and marketing of biotechnology and/or pro-biotic products. The company was formerly known as Genesis IBRC India Limited and changed its name to CCME Global Limited in March 2026. CCME Global Limited was incorporated in 1992 and is based in Eluru, India.
Details
Sector
Healthcare
Industry
Biotechnology
CEO
Ms. Poonam Chaturvedi
Headquarters
Eluru
Website
genesisiil.comExchange
View on BSE ↗Key stats
Market cap
₹189.19 Cr
EPS (TTM)
₹-0.50
Beta (1Y · daily vs NIFTY 50)
0.19
Beta (5Y · monthly vs NIFTY 50)
0.26
Shares float
78.06 L
EPS · quarter ended Jun 2026
₹-0.06
Financial Performance
01 · Financials
02 · Earnings Per Share (EPS)
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹0 | ₹0 | ₹0 | ₹0 | |
| EBITDA | ₹-13.74 L | ₹-3.80 Cr | ₹3.51 Cr | ₹-71.50 L |
| ₹-13.74 L | ₹-3.80 Cr | ₹3.51 Cr | ₹-71.50 L | |
| Diluted EPS | ₹-0.11 | ₹-2.92 | ₹2.7 | ₹-0.53 |
Total expenses (as filed), Employee benefit expense, Other expenses have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹8.97 Cr | ₹5.21 Cr | ₹8.84 Cr | ₹45.31 Cr | |
| — | — | — | ₹0 | |
| Stockholders' equity | ₹8.83 Cr | ₹5.03 Cr | ₹8.53 Cr | ₹40.07 Cr |
Total debt, Long-term debt, Current (short-term) debt, Others have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹-9.20 L | ₹-11,000 | ₹-3,000 | ₹5.10 Cr | |
| Investing cash flow | ₹0 | ₹0 | ₹0 | ₹0 |
| Financing cash flow | ₹8.52 L | ₹0 | ₹0 | ₹32.25 Cr |
| End cash position | ₹71,000 | ₹60,000 | ₹57,000 | ₹37.36 Cr |
Annual only — the data source has no quarterly cash-flow-statement coverage.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.48 L Cr | ₹1,846.4 | 37.1 | 5.37 | 13.7% | 0.06 | +11.9% | +12.3% |
| Divi's Laboratories Limited | ₹2.48 L Cr | ₹9,624 | 84.9 | 14.81 | 15.3% | 0.00 | +12.3% | +59.0% |
| Torrent Pharmaceuticals Limited | ₹1.88 L Cr | ₹4,985 | 78.8 | 22.38 | 25.8% | 1.79 | +21.5% | +36.5% |
| Apollo Hospitals Enterprise Limited | ₹1.28 L Cr | ₹8,835.5 | 61.5 | 13.52 | 20.5% | 0.90 | +15.7% | +14.2% |
| Lenskart Solutions Limited | ₹1.20 L Cr | ₹686.7 | 181.0 | 13.70 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.16 L Cr | ₹1,170.1 | 25.9 | 4.28 | 18.6% | 0.46 | +18.4% | +12.0% |
| Cipla Limited | ₹1.12 L Cr | ₹1,384.1 | 33.2 | 3.25 | 11.3% | 0.02 | +2.1% | -10.3% |
| Laurus Labs Limited | ₹1.09 L Cr | ₹2,034 | 99.7 | 20.52 | 16.8% | 0.48 | +22.0% | +123.5% |
| Max Healthcare Institute Limited | ₹1.02 L Cr | ₹1,066.6 | 70.4 | 9.50 | 13.4% | 0.32 | +19.0% | -8.0% |
| Dr. Reddy's Laboratories Limited | ₹1.01 L Cr | ₹1,211.2 | 30.5 | 2.68 | 11.4% | 0.21 | +3.2% | -7.4% |
| Manipal Health Enterprises Limited | ₹99,126.82 Cr | ₹760.95 | 150.7 | 11.76 | 7.8% | 1.53 | +18.0% | — |
| CCME GLOBAL LIMITED | ₹173.17 Cr | ₹38.27 | — | 4.32 | -1.8% | 0.00 | — | — |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Show all 20
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.